Craneware (LON:CRW) Stock Passes Below 200 Day Moving Average – Here’s Why

Posted by Kyle Jackson on Sep 3rd, 2026

Craneware plc (LON:CRW – Get Free Report) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1,381.53 and traded as low as GBX 1,316. Craneware shares last traded at GBX 1,326, with a volume of 130,256 shares changing hands.

Wall Street Analyst Weigh In

Separately, Berenberg Bank reduced their target price on Craneware from GBX 2,900 to GBX 2,600 and set a “buy” rating for the company in a research note on Friday, July 3rd. Four research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of GBX 2,222.75.

View Our Latest Analysis on Craneware

Craneware Trading Down 0.1%

The stock has a 50-day moving average of GBX 1,259.29 and a 200 day moving average of GBX 1,380.95. The stock has a market cap of £475.21 million, a PE ratio of 22.07 and a beta of 0.28. The company has a quick ratio of 1.00, a current ratio of 0.76 and a debt-to-equity ratio of 7.93.

Insider Buying and Selling at Craneware

In other Craneware news, insider Will Whitehorn acquired 640 shares of the company’s stock in a transaction dated Friday, July 3rd. The shares were acquired at an average cost of GBX 1,173 per share, with a total value of £7,507.20. Also, insider Keith Neilson acquired 9,074 shares of the business’s stock in a transaction dated Monday, July 6th. The stock was acquired at an average price of GBX 1,102 per share, for a total transaction of £99,995.48. 10.32% of the stock is owned by corporate insiders.

About Craneware

(Get Free Report)

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster – that simplify the complexities of healthcare finance and operations.